Clinical and analytical aspects of pyrrolizidine poisoning caused by South African traditional medicines

Therapeutic Drug Monitoring

Volumn 22, Issue 3, 2000, Pages 302-306

  Steenkamp, Vanessa ^a   Stewart, Michael J ^a,c   Zuckerman, Michele ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

Herbal medicines; Pyrrolizidine alkaloids; Toxicity; Veno occlusive disease

Indexed keywords

HERBACEOUS AGENT; PYRROLIZIDINE; RETRORSINE;

ARTICLE; ASCITES; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HEPATOMEGALY; HUMAN; INFANT; INTOXICATION; JAUNDICE; LIVER CIRRHOSIS; LIVER VENOOCCLUSIVE DISEASE; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; SOUTH AFRICA; TRADITIONAL MEDICINE;

ALANINE TRANSAMINASE; ASCITES; ASPARTATE AMINOTRANSFERASES; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; INFANT; LIVER; MALE; MEDICINE, AFRICAN TRADITIONAL; PLANTS, MEDICINAL; PYRROLIZIDINE ALKALOIDS; SOUTH AFRICA;

EID: 0034080001     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200006000-00011     Document Type: Article

References (22)

1. Bull L, Culvenor C, Dick A. The pyrrolizidine alkaloids; their chemistry, pathogenicity and other biologic properties. North Holland: North Holland Publishing; 1968.
2. Stegelmeier B, Edgar J, Colegate S, Gardner D, Schoch T, Coulombe R, et al. Pyrrolizidine alkaloid plants, metabolism and toxicity. J Nat Toxins 1999;8:95-116.
3. Willmot FC, Robertson GW. Senecio disease or cirrhosis of the liver due to Senecio poisoning. Lancet 1920;2:848-9.
4. Freiman I, Schmaman A, Zamit R, Appleberg M. Veno-occlusive disease of the liver - some new aspects. S Afr Med J 1968;42: 126-9.
5. Grobler A, Koen M, Brouwers F. Planttoksiene en lewersiektes by kinders in Pretoria en omgewing. Tijdschr Kindergeneeskd 1997; 65:99-104.
6. Birecka H, Catalfamo J, Eisen R. A sensitive method for the detetcion and quantitative determination of pyrrolizidine alkaloids. Phytochemistry 1981;20:343-4.
7. Stuart KL, Bras G. Veno-occlusive disease of the liver. Q J Med 1957;26:291-315.
8. Mclean E. The toxic actions of pyrrolizidine (Senecio) alkaloids. Pharmacol Rev 1970;22:429-83.
9. Roulet M, Laurini R, River L, Calame A. Hepatic veno-occlusive disease in a newborn infant of a woman drinking herbal tea. J Paediatr 1988;112:433-6.
10. Mattocks A, Jukes R. The simple detection of potentially toxic pyrrolizidine alkaloids under field conditions. The herbalist 1994;February:13-4.
11. Langer T, Mostl E, Chizzola R, Gutleb R. A competitive enzyme immunoassay for the pyrrolizidine alkaloids of the senecionine type. Planta Med 1996;62:267-71.
12. Couet CE, Crews C, Hanley AB. Analysis, separation and bioassay of pyrrolizidine alkaloids from Comfrey. Nat Toxins 1996;4: 163-7.
13. Crews C, Startin J, Clarke P. Determination of pyrrolizidine alkaloids in honey from selected sites by solid phase extraction and HPLC-MS. Food Addit Contam 1997;14:419-28.
14. Kew M, Yu M, Kedda M, Coppin A, Sarkin A, Hodkinson J. The relative roles of hepatitis B and C in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997;112: 184-7.
15. Madishona E, MacPhail A, Gordeuk V, Kedda M, Paterson A, Roualt T, et al. Dietary iron overload as a risk factor for hepatocellular carcinoma in black Africans. Hepatalogy 1998;27:1563-6.
16. van Rensburg S, Cook-Mozzafari P, van Schalkwyk D, van der Watt J, Vincint T, Purchase I. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and transkei. Cancer 1985;51:713-26.
17. McLean E. Senecio and other plants as liver poisons. Isr J Med Sci 1974;10:436-40.
18. Deyo J. Tier-2 studies on monocrotaline immunotoxicity in C57BL/6 mice. Toxicology 1991;70:313-25.
19. Baglin TP, Harper P, Marcus RE. Veno-occlusive disease of the liver complicating ABMT successfully treated with recombinant tissue plasminogen activator (rt-PA). Bone Marrow Transplant 1990;5:439-41.
20. Gluckman E, Jolivet I, Scrobohaci ML, Devergie A, Traineau R, Bourdeau-Esperou H, et al. Role of PGE1 to prevent venoocclusive disease of the liver after bone marrow transplantation. Nouv Rev Fr Hematol 1990;32:1-3.
21. Fogteloo AJ, Smid WM, Kok T, Van Der Meer J, Van Imhoff GW, Daenen S. Successful treatment of veno-occlusive disease of the liver with urokinase in a patient with non-Hodgkin's lymphoma. Leukemia 1993;7:760-3.
22. Leahey AM, Bunin NJ. Recombinant human tissue plasminogen activator for the treatment of severe hepatic veno-occlusive disease in pediatric bone marrow transplant patients. Bone Marrow Transplant 1996;17:1101-4.